{"id":"W1564728191","doi":"10.1038/bjc.2015.196","title":"Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; University Hospital Foundation","funders":"Astellas Pharma; GlaxoSmithKline; Exelixis; Genentech; AstraZeneca; Royal Marsden NHS Foundation Trust; Pfizer; Bristol-Myers Squibb","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Neutropenia; Expanded access; Internal medicine; Adverse effect; Clear cell renal cell carcinoma; Tyrosine-kinase inhibitor; Oncology; Confidence interval; Surgery; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009360113,0.0001848286,0.0005717744,0.00005934451,0.00005916099,0.0001390771,0.000322898,0.0000668848,0.0001707331],"category_scores_gemma":[0.0003542431,0.0001430708,0.0002247002,0.0002880718,0.00006964013,0.0002417356,0.00007646362,0.0004488051,0.000006861315],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005938195,"about_ca_system_score_gemma":0.001350143,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01165107,"about_ca_topic_score_gemma":0.008353048,"domain_scores_codex":[0.99732,0.000292012,0.0009238375,0.000230896,0.0008605194,0.0003727295],"domain_scores_gemma":[0.9983149,0.0001789997,0.0005319893,0.0002214073,0.0004122629,0.0003404314],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4221188,0.003729633,0.2359904,0.0001157257,0.0008685568,0.078101,0.00260506,0.0005265893,0.0004999231,0.00003239767,0.1483624,0.1070495],"study_design_scores_gemma":[0.3503276,0.002353071,0.6188308,0.0009538095,0.0008309233,0.00465334,0.0009550322,0.00005664918,0.002786877,0.0005374584,0.01740368,0.000310701],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9767106,0.01803557,0.00003336342,0.0009399445,0.0006858675,0.0004512414,0.0005527937,0.000007127797,0.002583457],"genre_scores_gemma":[0.9971575,0.0004641761,0.0003085327,0.0004654757,0.001235347,0.00002265373,0.00004358032,0.00001963948,0.0002830816],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3828404,"threshold_uncertainty_score":0.9949304,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1058398097867058,"score_gpt":0.3561710599735537,"score_spread":0.2503312501868479,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}